Literature DB >> 22267739

Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Rory N Pruitt1, Nicole M Chumbler, Stacey A Rutherford, Melissa A Farrow, David B Friedman, Ben Spiller, D Borden Lacy.   

Abstract

The principle virulence factors in Clostridium difficile pathogenesis are TcdA and TcdB, homologous glucosyltransferases capable of inactivating small GTPases within the host cell. We present crystal structures of the TcdA glucosyltransferase domain in the presence and absence of the co-substrate UDP-glucose. Although the enzymatic core is similar to that of TcdB, the proposed GTPase-binding surface differs significantly. We show that TcdA is comparable with TcdB in its modification of Rho family substrates and that, unlike TcdB, TcdA is also capable of modifying Rap family GTPases both in vitro and in cells. The glucosyltransferase activities of both toxins are reduced in the context of the holotoxin but can be restored with autoproteolytic activation and glucosyltransferase domain release. These studies highlight the importance of cellular activation in determining the array of substrates available to the toxins once delivered into the cell.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267739      PMCID: PMC3318759          DOI: 10.1074/jbc.M111.298414

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins.

Authors:  E Chaves-Olarte; P Löw; E Freer; T Norlin; M Weidmann; C von Eichel-Streiber; M Thelestam
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

2.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

3.  Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.

Authors:  Lea M Spyres; Jeremy Daniel; Amy Hensley; Maen Qa'Dan; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

4.  The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis.

Authors:  Cornelia Frisch; Ralf Gerhard; Klaus Aktories; Fred Hofmann; Ingo Just
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

5.  Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells.

Authors:  Gunther Pfeifer; Jörg Schirmer; Jost Leemhuis; Christian Busch; Dieter K Meyer; Klaus Aktories; Holger Barth
Journal:  J Biol Chem       Date:  2003-08-26       Impact factor: 5.157

6.  Low pH-induced formation of ion channels by clostridium difficile toxin B in target cells.

Authors:  H Barth; G Pfeifer; F Hofmann; E Maier; R Benz; K Aktories
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

7.  pH-induced conformational changes in Clostridium difficile toxin B.

Authors:  M Qa'Dan; L M Spyres; J D Ballard
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.

Authors:  Tor C Savidge; Wei-Hua Pan; Paul Newman; Michael O'brien; Pauline M Anton; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

9.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  D M Lyerly; L A Barroso; T D Wilkins; C Depitre; G Corthier
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 10.  Active and passive immunization against Clostridium difficile diarrhea and colitis.

Authors:  Paul J Giannasca; Michel Warny
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641

View more
  35 in total

1.  Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.

Authors:  Yongrong Zhang; Therwa Hamza; Si Gao; Hanping Feng
Journal:  Biochem Biophys Res Commun       Date:  2015-02-26       Impact factor: 3.575

2.  A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Zhifen Zhang; Kim Rosenthal; Rob Woods; Xiaofang Jin; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Roman A Melnyk; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

3.  Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Kim Rosenthal; Rob Woods; Xiaofang Jin; Melanie D Ohi; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

4.  Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore.

Authors:  Zhifen Zhang; Minyoung Park; John Tam; Anick Auger; Greg L Beilhartz; D Borden Lacy; Roman A Melnyk
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

5.  Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.

Authors:  Jhansi L Leslie; Sha Huang; Judith S Opp; Melinda S Nagy; Masayuki Kobayashi; Vincent B Young; Jason R Spence
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 6.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

Review 7.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

8.  Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.

Authors:  Joseph W Alvin; D Borden Lacy
Journal:  J Struct Biol       Date:  2017-04-19       Impact factor: 2.867

9.  Crystal structure of Clostridium difficile toxin A.

Authors:  Nicole M Chumbler; Stacey A Rutherford; Zhifen Zhang; Melissa A Farrow; John P Lisher; Erik Farquhar; David P Giedroc; Benjamin W Spiller; Roman A Melnyk; D Borden Lacy
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

Review 10.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.